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Objective: The purpose of this controlled laboratory study was to determine the efﬁcacy of Interleukin-1
Receptor Antagonist Protein (IRAP) treatment as an early intervention strategy by examining the changes
in microRNA and mRNA expression in cartilage in an ex-vivo porcine knee joint impact model.
Methods: Custom impact device was used to create replicable injury ex-vivo to intact porcine knee joint.
Injury was caused by dropping a 10 kg weight one time from 1 m directly above the knee in extension.
One hour after impact 20 mg/ml IRAP solution was intra-articularly injected. At 8 h post-injury, cartilage
samples were harvested for cell viability and genetic expression analysis. Genetic expression of miR-27b,
miR-140, miR-125b, ADAMTS-4, ADAMTS-5, MMP-3, IL-1b, and TNF-a were analyzed by RT-PCR. Cell
viability image analysis was performed using ImageJ software. Groups were compared by analysis of
variance (ANOVA) followed by Tukey's post-hoc test. A P-value <0.05 was considered signiﬁcant.
Results: At 8 h after IRAP treatment, expressions of ADAMTS-4, ADAMTS-5, MMP-3, IL-1b, and TNF-a in
cartilage were signiﬁcantly down-regulated from injury group (all P < 0.001). MiR-140, miR-125b, and
miR-27b expressions were signiﬁcantly up-regulated after treatment as compared to control and injury
groups (all P < 0.001).
Conclusion: This study demonstrates that IRAP treatment administered during acute phase of cartilage
impact injury increases expression levels of miR-140, miR-125b, and miR-27b in cartilage, indicating
increased inhibition of their respective matrix-degrading enzymes. Clinically, these ﬁndings support the
potential of IRAP treatment as an early intervention strategy for the prevention of cartilage degeneration
after impact injury.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Traumatic injury to the knee has been shown to lead to Post-
Traumatic Osteoarthritis (PTOA)1. Cartilage degeneration can
occur within 15 years of a traumatic knee injury; therefore, PTOA
has become more prevalent in young individuals and is responsible
for up to 12% of OA cases2. Current therapeutic strategies for PTOA,: L. Kaplan, 1251 Memorial
-689-1328; Fax: 1-305-689-
emaras), treiner@med.miami.
g), kaplan@med.miami.edu
ternational. Published by Elsevier Lsuch as rehabilitation, molecular-based injections, total joint re-
placements, etc., are most often administered after the injured
cartilage has begun to degenerate and cause disabling pain to the
patient. At this point, the therapies are merely to assuage pain and
are unable to reverse the permanent cartilage damage. Unlike
primary degenerative OA, an exact time of injury can be correlated
to the initiation of the disease and presents the opportunity for
intervention to prevent PTOA development.
After a traumatic knee injury, with or without cartilage fracture,
inﬂammatory cytokine concentration increases in the synovial ﬂuid
and injured tissues3. The primary cytokines produced in an in-
ﬂammatory environment are Interleukin (IL)-1b and Tumor Ne-
crosis Factor (TNF)-a3,4. Up-regulation of IL-1b after injury triggers
a catabolic pathway, disrupting cellular homeostasis by increasingtd. All rights reserved.
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and aggrecan production5. This imbalance of anabolic and catabolic
processes can be traced back to aberrant epigenetic regulation by
microRNAs (miRNAs), ~20-nucleotide non-coding RNAs6. In their
simplest form, miRNAs negatively regulate target messenger RNA
(mRNA) post-transcriptionally by promoting degradation, dead-
enylation, or repression of translation7. Three miRNAs miR-125b,
miR-140 and miR-27b, among others, have been implicated in the
progression of OA and their expressions have been shown to be
inﬂuenced by an inﬂammatory environment8e10. MiR-125b and
miR-140 have been identiﬁed as regulators of aggrecanase-1 (A
Disintegrin And Metalloproteinase with Thrombospondin Motifs
[ADAMTS]-4)8 and aggrecanase-2 (ADAMTS-5)9, respectively, and
are expressed signiﬁcantly lower in OA and IL-1b-treated chon-
drocytes than in normal chondrocytes. MiR-27b directly regulates
Matrix Metalloproteinase (MMP)-13 and its expression is signiﬁ-
cantly decreased in OA chondrocytes and is regulated by the IL-1b-
activated catabolic pathway10. Additionally, MMP-3, which cleaves
proteoglycans and is highly expressed in OA cartilage, activates pro-
MMP-13, furthering matrix breakdown11. Proper regulation of
aggrecanases and collagenases is critical to achieve homeostasis in
cartilage after injury. Thus, there is a substantial need for a method
of early intervention that will effectively prevent or delay the
degeneration of cartilage after acute traumatic injury.
IL-1 Receptor Antagonist Protein (IRAP), naturally occurring in
the body, effectively binds to the IL-1 receptor on the chondrocyte
membrane and blocks IL-1a/b from triggering its catabolic
pathway12. Preclinical and clinical studies5,12e14 have demonstrated
the efﬁcacy of IRAP in reducing catabolic activities and joint
discomfort in models of established OA. Recent studies using a
mouse articular cartilage fracture model have shown that IRAP, as
an early intervention treatment, signiﬁcantly reduced cartilage
degeneration and synovial inﬂammation15,16. However, how IRAP
treatment affects catabolic genetic regulation in cartilage during
the acute phase of impact injury has not yet been elucidated.
Therefore, the objective of this controlled laboratory study was
to determine the efﬁcacy of IRAP treatment as an early intervention
strategy by examining the changes in miRNA and mRNA expression
in cartilage after impact injury. Our hypothesis was that early
intervention with IRAP during the acute phase of cartilage injury
can modulate catabolic and inﬂammatory gene expressions caused
by impact by altering the expressions of miRNA.
Methods and materials
Injury model development
A custom impact device was developed to create replicable
injury ex-vivo to intact porcine knee joint. Porcine legs from 35 to
40 kg pigs were acquired from the University of Miami Department
of Veterinary Resources Tissue Sharing program (Institutional An-
imal Care and Use Committee approved source) and were dis-
articulated at the hip within 2 h of death. Skin and muscle
surrounding both joints were removed to ﬁt the leg properly in
extension in a conﬁned chamber of the impact device, while
maintaining the synovial membrane and joint capsule intact. The
conﬁned chamber prevented knee ﬂexion upon impact. An impact
cap comprised of a polycarbonate tube and metal plate was placed
securely over the femoral head to ensure ﬂat impact surface. A knee
joint from each pig was randomly selected and subjected to an
impact force about 4.6 kN by dropping a 10 kg weight one time
from1m directly above the knee in extension. The impact forcewas
chosen based on average mass withstood per leg (40 kg pig/4
legs ¼ 10 kg/leg). The chosen impact force did not result in visible
cartilage damage or bone fracture. A force transducer (OmegaDLC101 Impact Sensor, Omega Engineering Inc.) was placed below
the platform on which the leg stood to assure impact force repro-
ducibility. The contralateral joint of the same pig (control) was
placed within chamber of the impact device but was not subjected
to impact. Immediately after impact, limbs werewrapped in saline-
soaked gauze to prevent dehydration and placed in humidiﬁed
chamber at physiological temperature 37C and 20% oxygen until
time point. At 1 h post-impact, control and injury (impact without
treatment) joints received 1mL of sterile Phosphate Buffered Saline
(PBS) injections to simulate intra-articular injection.
To determine appropriate end time point for genetic changes to
take place, cartilage samples from impacted areas on femoral
condyles of control and injury knees were harvested at 3 and 8 h
post-impact, ﬂash-frozen, and stored at 80C for genetic expres-
sion analysis. MiR-140, miR-125b, miR-27b, IL-1b, TNF-a, MMP-3,
ADAMTS-4, and ADAMTS-5 were selected as indicators of injury
for model development. Meniscus samples from impacted region
were also harvested and stored for genetic expression analysis for
subsequent treatment study.
Fuji ﬁlm pressure and area analysis
A medium-grade pressure sensitive ﬁlm (FujiFilm; Sensor
Products, Inc. Madison, NJ) was used to determine the contact area
and pressure created by the 10 kg impact, as previously described
by Clark et al.17. In brief, the patellofemoral tendon and synovial
membrane were dissected to allow access into the knee joint. The
ﬁlmwas sealed between thin polyethylene adhesive layers, and two
strips of 2  6 cm2 were inserted into the femoral-tibial joint in an
anterior/posterior direction, separated by the anterior and poste-
rior cruciate ligaments. After impact, digital images of the Fujiﬁlm
stain were obtained at a resolution of 600 ppi using a digital
scanner. To verify the linear relationship between applied pressure
and stain intensity, Fujiﬁlm strips underwent a series of four static
load tests. Compressive loads, ranging from 15 to 40 MPa, were
applied by a 3.36 mm diameter cylindrical indentor using an Ins-
tron materials-testing machine (Instron Co., Norwood, MA).
Each Fujiﬁlm stain image underwent initial processing to ac-
count for the granular texture of the ﬁlm (MATLAB 2014a)18. Images
were divided into 4 4 pixel areas. The mean intensity of the pixels
in the area was then applied across the entire 4  4 pixel area.
Pressures calculated from standard curve were applied to impacted
stains to produce a pressure distribution map. Injured area deﬁned
by pressures >20 MPa were then calculated. Multiple studies re-
ported impact stresses greater than 20 MPa led to chondrocyte
death, collagen matrix rupture, and cartilage degeneration19e24.
Immunohistochemical analysis
Cartilage samples from impacted areas on control and injured
joints were placed in 10% neutral buffered formalin for 24 h. The
samples were parafﬁn embedded, and sectioned cross-sectionally
(5 mm) for staining. Immunohistochemistry was used to localize
IL-1b and TNF-a cytokine proteins within the cartilage tissue.
Endogenous peroxidase was quenched for 30 min in the dark with
0.3% H2O2 in distilled water. After rinsing with distilled water and
PBS, 10% normal horse serum was used to block nonspeciﬁc back-
ground. Sections were stained with a rabbit polyclonal antibody
against human IL-1b (anti-human IL-1b (H-153), sc-7884; Santa
Cruz Biotechnology, Inc) or human TNF-a (anti-human TNF-a (H-
156), sc-8301; Santa Cruz Biotechnology, Inc) at 1:50 dilution at 4C
for 18 h. Negative staining control sections were incubated with
antibody diluent without primary antibody and then carried
through the same secondary antibody and detection protocols as
the positive control sections. Chromogenic detection was achieved
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counterstaining with hematoxylin. Sections were observed and
digitally photographed at 200 magniﬁcation.
IRAP administration
For IRAP treatment, the procedure described previously was
used to injure the joint. One hour after impact, 20 mg of recombi-
nant human IRAP (PeproTech; Rocky Hill, NJ) in 1 mL of PBS was
administered to injured knee via intra-articular injection. The dose
(20 mg/mL) was calculated from successful reports of inhibition of
catabolic gene expression with IRAP in porcine knee tissues in vi-
tro13. The contralateral joint of the same pig served as the control in
the same manner previously described. At 8 h after injury, samples
from impacted region on articular cartilage on femoral condyles
and meniscus from both groups were harvested, ﬂash-frozen, and
stored at 80C for analyses of miRNA and mRNA expressions.
Analysis of chondrocyte viability
Cartilage samples from control, injury, and treatment joints
were stained for cell viability at time of harvest. In brief, a 100-
micron thick full-depth sample was prepared and incubated in
PBS containing 1 mmol/L ethidium homodimer-1 and 1 mmol/L
calcein AM from the Live/Dead Viability/Cytotoxicity Kit (Invi-
trogen). Staining was visualized on an inverted ﬂuorescent micro-
scope with 495 nm/515 nm excitation/emission for calcein (live
cells) and 495 nm/635 nm excitation/emission for ethidium
homodimer (dead cells).
Image analysis was conducted to determine the number of live
and dead cells, as described in our previous study24. A deﬁned re-
gion of interest was identiﬁed (1.11 mm wide  0.88 mm deep at
the center of the sample, measured from the surface down) from
images taken through a 10 objective lens utilizing MATLAB
R2014a (MathWorks Natick, MA). The resulting images were
analyzed with ImageJ software, and percent cell viability (number
of live cells  100/total number of cells) was calculated.
Analyses of mRNA and miRNA expressions
Cartilage tissue adjacent to the areas used for cell viability
staining was processed for analyses. For meniscus, tissue samples
from impacted region were used for analyses. Total RNA was iso-
lated using the guanidinium thiocyanate-phenol-chloroform
extraction method25. For mRNA expression analyses, the High Ca-
pacity cDNA Reverse Transcription Kit (Applied Biosystems) was
used to synthesize cDNA from 0.25 mg total RNA following manu-
facturer's instructions. For miRNA expression analyses, the qScript
microRNA cDNA synthesis kit (Quanta Biosciences) was used to
polyadenylate miRNAs and synthesize cDNA from 0.25 mg total RNA
following manufacturer's instructions. Expression of selected
mRNA and miRNA was analyzed using StepOnePlus (Applied Bio-
systems) quantitative real-time PCR system. Expression of ribo-
somal 18S and RNU6B were used as endogenous controls for mRNA
and miRNA, respectively. Primer sequences are listed in Table I.
Quantiﬁcation of expression levels was determined by the 2DDCt
method and normalized to expression levels of respective control
leg.
Statistical analysis
In this study, we analyzed 3 h control joints (n ¼ 3), 8 h control
joints (n¼ 10), 3 h injury joints (n¼ 3), 8 h injury joints (n¼ 5), and
8 h treatment joints (n ¼ 5). From each joint, four tissue samples
each were harvested from the impacted regions of the femoralcondyle and meniscus. The samples from each joint were then
averaged prior to statistical analysis. In model development, com-
parisons between injured area and maximum stress on the medial
and lateral condyles and between control and injury groups at 3
and 8 h were performed by two-sample two-tailed Student's t-test.
For statistical analysis of IRAP treatment, comparison of control,
injury, and treatment groups at 8 h post-injury was performed by a
one-way analysis of variance (ANOVA) followed by Tukey's post-hoc
test (MATLAB R2014a). For all tests, a P-value <0.05 was considered
statistically signiﬁcant.
Results
Model development
The average impact load was 4.7 ± 1.6 kN (n¼ 8) as measured by
the impact force sensor below the platform. After creating a stan-
dard curve (Fig. 1), pressure distribution analysis (Fig. 2) showed an
average combined injured area of 23.5 ± 1.9 mm2 (n ¼ 8) greater
than 20 MPa on both medial and lateral condyles with the lateral
and medial condyles having roughly equal injured areas (lateral:
9.6 ± 2.7 mm2, medial: 8.4 ± 3.2 mm2, P ¼ 0.75). In addition, there
was no signiﬁcant difference betweenmaximum pressure recorded
on medial (25.1 ± 1.9 MPa) and lateral (25.5 ± 1.1 MPa) condyles
after impact (P ¼ 0.64).
Analyses of mRNA and miRNA expression in cartilage after
injury showed an increase in ADAMTS-4 (P ¼ 0.0001) and MMP-3
(P ¼ 0.001) at 8 h and ADAMTS-5 (P ¼ 0.05, 0.001) expression at
3 and 8 h, respectively [Fig. 3(A)]. IL-1b and TNF-a were signiﬁ-
cantly up-regulated at 3 and 8 h post-impact, maintaining similar
levels of up-regulation across both time points (P < 0.01). Increased
IL-1b and TNF-a expression in injured cartilage 8 h post-impact was
veriﬁed by immunohistochemical staining (Fig. 4). At 3 h post-
injury, miR-140 and miR-125b were signiﬁcantly up-regulated
(both P < 0.05), but at 8 h post-injury, miR-140 and miR-125b
were signiﬁcantly down-regulated (P ¼ 0.03, 0.04 respectively)
[Fig. 3(B)].
Effect of IRAP treatment on cell viability and gene expression
At 8 h post-injury and treatment, chondrocyte viability signiﬁ-
cantly decreased in injury group as compared to control
(62.3 ± 5.9% vs 82.2 ± 2.5%, P ¼ 0.013) (Fig. 5). There were no sig-
niﬁcant differences found between control and treatment
(82.2 ± 2.5% vs 74.7 ± 3.2%, P ¼ 0.42) nor between injury and
treatment (P ¼ 0.12).
Signiﬁcant effect of treatment at 8 h post-injury was shown for
aggrecanase and inﬂammatory cytokine expressions [Fig. 6(A)].
Expressions of ADAMTS-4, ADAMTS-5, MMP-3, IL-1b, and TNF-a in
cartilage were signiﬁcantly lower than injury group expressions (all
P < 0.001). IRAP treatment after injury also signiﬁcantly affected
cartilage miRNA expressions [Fig. 6(B)]. Expressions of miR-140,
miR-125b, and miR-27b were signiﬁcantly up-regulated after
treatment as compared to control and injury groups (all P < 0.001).
To determine the metabolic effect of IRAP on cartilage, we
examined the relative expression of aggrecan and collagen II
[Fig. 6(A)]. At 8 h post-impact, aggrecan expression was signiﬁ-
cantly increased (P ¼ 0.001) as compared to controls. After injury
and treatment, aggrecan expression was not signiﬁcantly different
from the control or injury groups (P ¼ 0.18 and 0.26, respectively).
No signiﬁcant difference in collagen II expression was observed
between groups (ANOVA P ¼ 0.377) (data not shown).
Because this model allows for simultaneous treatment of intra-
articular tissues, we examined themRNA andmiRNA expressions in
meniscus 8 h after injury and IRAP treatment [Fig. 7(A) and (B)].
Table I
Quantitative real-time PCR primers
Gene Primer sequences Reference/
GenBank/
miRbase
Accession#
ADAMTS-4 F:50-AGGAGGAGATCGTGTTTCCAGAGA-30 26
R:50-AAAGGCTGGCAAGCGGTACAACAA-30
ADAMTS-5 F:50-TTCGACATCAAGCCATGGCAACTG-30 26
R:50-AAGATTTACCATTAGCCGGGCAGG-30
IL-1b F:50-AATGCAACAGGGTGTGGGC-30 X74568.1
R:50-CCACACCAGAAGTGCATTTG-30
TNF-a F:50-CCCTGTGAGGGGGCAGGACA-30 X54859.1
R:50-ACCCAAGGACCCCAGCGAGT-30
MMP-3 F:50-TCCTGATGTTGGTTACTTCAGCAC-30 27
R:50-TTGACAATCCTGTAAGTGAGGTCATT-30
Aggrecan (AGN) F:50-AGACAGTGACCTGGCCTGAC-30 28
R:50-CCAGGGGCAAATGTAAAGG-30
Collagen II (COL2) F:50-TGAGAGGTCTTCCTGGCAAA-30 28
R:50-ATCACCTGGTTTCCCACCTT-30
18S F:50-CGGCTACCACATCCAAGGA-30 26
R:50-AGCTGGAATTACCGCGGCT-30
hsa-miR-140-5p 50-AGTGGTTTTACCCTATGGTAG-30 MIMAT0000431
ssc-miR-125b-5p 50-TCCCTGAGACCCTAACTTGTGA-30 MIMAT0000423
hsa-miR-27b-5p 50-AGAGCTTAGCTGATTGGTGAACA-30 MIMAT0004588
RNU6B F: 50-GCTTCGGCAGCACATATACTAAAAT-30 29
R: 50-CGCTTCACGAATTTGCGTGTCAT-30
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were signiﬁcantly up-regulated in meniscus tissue (P ¼ 0.03, 0.001,
0.005, and 0.001, respectively). ADAMTS-5, while not signiﬁcant,
consistently tended towards up-regulation in the injury group
(P ¼ 0.09). Expression of miR-27b after injury was signiﬁcantly
decreased as compared to control (P ¼ 0.01). However, when IRAP
was administered 1 h after injury, expressions of MMP-3, IL-1b and
TNF-a were signiﬁcantly lower than the injury group (P ¼ 0.009,
0.003, and 0.003, respectively). Expressions of miR-125b and miR-
27b were also signiﬁcantly increased in meniscus after injury and
treatment as compared to control (P ¼ 0.005 and 0.001, respec-
tively) and as compared to injury group (P ¼ 0.002 and P < 0.001,
respectively).
Discussion
The ex-vivo intact joint impact injury model developed in this
study presents a method to examine the acute phase of impact
injury and can be used to investigate the efﬁcacy of potential
treatments. A detailed understanding of the events that occur
during the acute phase injury in cartilage can provide great insightFig. 1. Calibration curve showing a linear relationship between grayscale image in-
tensity and applied pressure.or help choose suitable time points, targets, and methods of
interventional treatment to prevent or delay the progression of
PTOA. The results of this study support the hypothesis by demon-
strating that early interventionwith IRAP during the acute phase of
cartilage injury signiﬁcantly up-regulated expression of miRNA and
inhibited up-regulation of their target mRNA induced by impact.
This is the ﬁrst study to report differential miRNA expressions in
cartilage after impact injury and the effects of IRAP intra-articular
treatment on miRNA expression.
In effort to determine the mechanism of PTOA development, re-
searchers have developed various in-vitro and in-vivo models of
impact injury to cartilage. Cartilage explant models30e32 have the
ability to transduce the mechanical forces associated with impact
injuries; however, they are maintained in non-physiological culture
conditions with high amounts of nutrients and oxygen as compared
to the avascular, hypoxic environment within the knee joint. Rundell
et al. determined that the true cartilage explant response to me-
chanical loading is altered by equilibration in standard culture me-
dium33.While the in-vivo impact injurymodel20,34 remains the “gold-
standard” for investigating the true response of cartilage after injury,
the ex-vivo intact joint injury model utilized in this study provides a
physiological acute injury responsewithminimal disruption of native
tissue environment. The ex-vivo injury model has proven consistent
with in-vivomodels of acute cartilage injury that reported peak IL-1b
expression within 4 h of injury in an in-vivomurine model34.
In normal joint loading in vivo, the force is distributed 70% to
medial condyle and 30% to the lateral condyle35. However, even
though the forces are unequally distributed, the pressures remain
similar due to the larger contact area and cartilage thickness of the
medial condyle36. Based on the Fujiﬁlm data, it was found that both
femoral condyles were injured simultaneously while similar
maximum contact stresses on the condyles were observed,
showing that a physiological distribution of stresses on the carti-
lage was effectively created in the ex-vivo injury model using an
intact joint. Furthermore, the contact stresses, greater than 20MPa,
covered a total combined area of 23.5 ± 1.9 mm2 of cartilage. The
impact forces applied and pressures recorded are within the range
of deleterious cartilage impact as pressures of 20 MPa or greater
have been reported to lead to critical cell death, collagen matrix
rupture, and eventual cartilage degeneration in several long term
in-vitro and in-vivo studies20e23. It can be inferred that the physi-
ologically relevant acute injury response of cartilage is accurately
represented in this model, as conﬁrmed by viability staining of
injured area.
Aggrecanases are integral components of cartilage homeostasis
and matrix remodeling; however, after traumatic impact injury,
production of these enzymes becomes signiﬁcantly up-regulated,
resulting in a compromised matrix structure with reduced me-
chanical stability32. Loss of aggrecan in the cartilage matrix is
observed as one of the earliest changes in cartilage degeneration
and OA progression37 with changes reported as early as 1 day after
injury38. Down-regulation of miR-125b and miR-140 has been
directly linked to elevated expression levels of ADAMTS-4 and
ADAMTS-5, respectively8,9. At 8 h post-injury, miR-140 and miR-
125b expressions were signiﬁcantly down-regulated, indicating
that at 8 h after injury, cartilage has reduced inhibition of aggre-
canases. However, IRAP intra-articularly injected 1 h after impact
injury inhibits catabolic aggrecanase expression with increased
expressions of corresponding regulatory miRNAs. Therefore, IRAP
treatment may inhibit the production of aggrecanase production
through the up-regulation of miR-140 and miR-125b, thereby
preventing potential cartilage degradation.
MMP-3 cleaves aggrecan and activates pro-MMP-13, the most
potent collagen-degrading enzyme11,39. MMP-3 expression was
signiﬁcantly up-regulated at 8 h after injury. In injured cartilage
Fig. 2. Example analysis of Fujiﬁlm: typical medial condyle stain (AeC) and typical lateral condyle stain (DeF). A&D. Adjusted grayscale stain of digital raw stain (600 ppi) with
averaged intensities calculated over areas 4  4 pixel areas and applied pressure distribution map. B&E. Colormap of pressures. C&F. Region identiﬁed in white with >20 MPa
applied pressure.
A.A. Genemaras et al. / Osteoarthritis and Cartilage 23 (2015) 2036e20442040with IRAP treatment, MMP-3 expression is no longer signiﬁcantly
up-regulated as compared to controls. Furthermore, as the direct
regulator of MMP-1310, miR-27b expression was signiﬁcantly up-
regulated after IRAP treatment, similarly indicating increasedFig. 3. (A,B) Relative expressions of inﬂammatory cytokines and catabolic enzymes (A) and
*indicates signiﬁcance P < 0.05. Refer to text for exact P-value. (CeH) Immunohistochemica
(E,H). Negative control sections for control (B) and injured (F) cartilage showed negligibleinhibition of collagenase. The expressions of these degenerative
enzymes in the acute phase of injury and their subsequent inhibi-
tion after IRAP treatment greatly support the potential of early
intervention to prevent cartilage degeneration.expressions of miR-125b, miR-140, and miR-27b (B) at 3 and 8 h after impact injury.
l assessments of control and injured cartilage for expressions of IL-1b (D,G) and TNF-a
staining. Representative samples are shown. Original magniﬁcation  200.
Fig. 4. Representative cell viability staining of cartilage at 8 h post-injury and IRAP treatment (10) A. Control; B. Injury, No Treatment; C. Injury, IRAP treatment. Live cells (green),
dead cells (red).
Fig. 5. Relative expressions of inﬂammatory cytokines, catabolic enzymes, and aggrecan (A) and expressions of miR-125b, miR-140, and miR-27b (B) in control, injured, and treated
cartilage at 8 h after impact injury. *indicates signiﬁcance P < 0.05. Refer to text for exact P-value.
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other downstream targets in the IL-1 pathway, such as nuclear
factor (NF)-kb, protein 38 MAP kinase (p38 MAPK), and c-Jun N-
terminal kinase (JNK) pathway. Inhibition of the NF-kb, p38 MAPK,
and JNK pathways signiﬁcantly suppressed IL-1-induced aggreca-
nase expression and activity in chondrocytes40. Additionally, in IL-1
stimulated OA chondrocytes, NF-kb inhibitors signiﬁcantly
increased miR-27b expression10. Nonetheless, the evidence of in-
hibition of catabolic gene expression in acutely injured cartilage
after IRAP treatment should be considered preliminary; therefore,
any ﬁndings need to be conﬁrmed and expanded upon in longi-
tudinal in-vivo studies.
Inﬂammation in the cartilage and knee joint, driven by IL-1b and
TNF-a5,41, plays a crucial role in the development of OA. High me-
chanical stress on chondrocytes activates the IL-1 pathway and
results in the secretion of IL-1b14,41. It is well understood that
exogenous IL-1b secreted by surrounding knee tissues incites a
cascading effect on the catabolic responses of cartilage5. In this
study, IL-1b and TNF-a are signiﬁcantly up-regulated at 3 h and
remain up-regulated at 8 h after impact injury as shown by gene
expression analysis and immunohistochemistry. Concurrently,Fig. 6. Relative expressions of inﬂammatory cytokines and catabolic enzymes (A) and expre
at 8 h after impact injury. *indicates signiﬁcance P < 0.05. Refer to text for exact P-value.mechanical injury incites transient up-regulation of miR-125b,
miR-140, and ADAMTS-5 at 3 h post-impact. However, at 8 h,
secreted IL-1b binds to the IL-1 receptor, which incites the IL-1
catabolic pathway, and then down-regulates miR-140 and miR-
125b. As a result, elevated aggrecanase and inﬂammatory cyto-
kine expressions remain at 8 h post-injury. Nevertheless, after
intra-articular injection of IRAP given 1 h after impact, IL-1b and
TNF-a were no longer up-regulated at 8 h. Administration of IRAP
serves to antagonize the catabolic cascade (Fig. 7) by preventing IL-
1b from binding to the IL-1 receptor on the cell membrane, and
inhibits the paracrine and autocrine effects of IL-1b secreted due to
mechanical loading12. Therefore, expressions of miR-140 and miR-
125b remain elevated and expressions of aggrecanases and in-
ﬂammatory cytokines are down-regulated.
At 8 h, aggrecan expression was signiﬁcantly increased by
impact. Previous studies have reported transient up-regulation of
aggrecan during the early phase of injurious compression42e44.
However, consistent with previous studies in meniscus and carti-
lage tissues13,14, we found no signiﬁcant differences in aggrecan or
collagen II expressions between injury and treatment groups at 8 h.
Therefore, the transient up-regulation in aggrecan expression wasssions of miR-125b, miR-140, and miR-27b (B) in control, injured, and treated meniscus
Fig. 7. A proposed mechanism of IRAP treatment. Impact injury causes up-regulation of IL-1b expression and secretion, which binds to the IL-1 receptor, incites the IL-1 catabolic
pathway, and results in down-regulated miR-140 and miR-125b expressions and up-regulated aggrecanase expressions. IRAP prevents IL-1b from binding to the IL-1 receptor on the
cell membrane and inhibits the paracrine and autocrine effects of IL-1b secreted. Therefore, expressions of miR-140 and miR-125b remain elevated due to mechanical loading and
expressions of aggrecanases and inﬂammatory cytokines are down-regulated. Up-regulation or down-regulation of a speciﬁc gene is represented by an upward or downward arrow,
respectively. All listed targets have been validated. The miRNA targets listed include aggrecanase-1 (ADAMTS-4), aggrecanase-2 (ADAMTS-5), and collagenase-3 (MMP-13).
A.A. Genemaras et al. / Osteoarthritis and Cartilage 23 (2015) 2036e20442042caused by mechanical injury to cartilage and not by increased IL-1b
expression.
In the ex-vivo injury model, the meniscus was also injured in a
physiologically compressive manner. Impact injury caused signiﬁ-
cant down-regulation of miR-27b and signiﬁcant up-regulation of
catabolic enzymes and inﬂammatory cytokines in meniscus. After
injury and IRAP treatment, miR-125b and -27b were signiﬁcantly
up-regulated, and catabolic enzyme and inﬂammatory cytokine
expressions in meniscus were signiﬁcantly reduced through a
mechanism comparable to cartilage. Although articular cartilage
and meniscus are primarily made of chondrocytes, the two tissues
distribute loads differently under impact. Different distributed
loads, along with inherent genetic and material properties45, could
the differences in the miRNA responses after impact from cartilage
and meniscus tissues.
Upon the comparison of the control, injury, and treatment
groups, a signiﬁcant decrease in cell viability was seen between
control and injury groups. The observed decrease in viability and
region of cell death is consistent with in-vitro explant models19,23
and clinical studies46. While most of the superﬁcial layer chon-
drocytes would have died by necrosis from the excessive strain
induced by impact47, we expect that IRAP treatment administered
1 h after impact may have prevented IL-1b from inciting cellular
apoptosis by blocking the IL-1 receptors48,49.
The rationale for administering treatment at 1 h after injury was
based on the need to demonstrate proof of concept but probably
not mimic a clinically relevant situation in the health care system
where access to care is limited. The model utilized in this study
presents the ability to monitor the acute events after injury whilemaintaining the physiological environment of the knee joint tis-
sues. A possible limitation of this model is the inability to perform
long-term studies. While cartilage tissue remains viable for over
24 h after donor death50, meniscus tissue viability could decrease
without renewed blood supply.
In summary, this study demonstrates that IRAP treatment
administered during acute phase of articular cartilage impact injury
increases expression levels of miR-140, miR-125b, and miR-27b
with signiﬁcant down-regulation of inﬂammatory cytokines and
matrix-degrading enzymes. The aberrant regulation of degenera-
tive enzymes and inﬂammatory cytokines in cartilage, along with a
decrease in chondrocyte viability, after impact injury increases the
risk of PTOA development. Clinically, these ﬁndings support the
potential of IRAP treatment as an early intervention strategy for the
prevention of cartilage degeneration after impact injury.Author contributions
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